Ascaso-del-Rio, A.; Camargo-Mamani, P.; Gilaberte, I.; DÃez-Hochleitner, M.; Laredo-Velasco, L.; Iglesias-Hernangómez, T.; Salas-Butrón, M.R.; Galán Caballero, L.; DÃaz-Rengifo, I.A.; Pérez-Ingidua, C.;
et al. Bioequivalence Study of Two Oral Methocarbamol Formulations in Healthy Subjects Under Fasting Conditions: A Randomized, Open-Label, Crossover Clinical Trial. Pharmaceuticals 2025, 18, 354.
https://doi.org/10.3390/ph18030354
AMA Style
Ascaso-del-Rio A, Camargo-Mamani P, Gilaberte I, DÃez-Hochleitner M, Laredo-Velasco L, Iglesias-Hernangómez T, Salas-Butrón MR, Galán Caballero L, DÃaz-Rengifo IA, Pérez-Ingidua C,
et al. Bioequivalence Study of Two Oral Methocarbamol Formulations in Healthy Subjects Under Fasting Conditions: A Randomized, Open-Label, Crossover Clinical Trial. Pharmaceuticals. 2025; 18(3):354.
https://doi.org/10.3390/ph18030354
Chicago/Turabian Style
Ascaso-del-Rio, Ana, Paola Camargo-Mamani, Inmaculada Gilaberte, Mónica DÃez-Hochleitner, Leonor Laredo-Velasco, Teresa Iglesias-Hernangómez, MarÃa Rosario Salas-Butrón, Laura Galán Caballero, Iván Alejandro DÃaz-Rengifo, Carla Pérez-Ingidua,
and et al. 2025. "Bioequivalence Study of Two Oral Methocarbamol Formulations in Healthy Subjects Under Fasting Conditions: A Randomized, Open-Label, Crossover Clinical Trial" Pharmaceuticals 18, no. 3: 354.
https://doi.org/10.3390/ph18030354
APA Style
Ascaso-del-Rio, A., Camargo-Mamani, P., Gilaberte, I., DÃez-Hochleitner, M., Laredo-Velasco, L., Iglesias-Hernangómez, T., Salas-Butrón, M. R., Galán Caballero, L., DÃaz-Rengifo, I. A., Pérez-Ingidua, C., Vargas-Castrillón, E., & Portolés-Pérez, A.
(2025). Bioequivalence Study of Two Oral Methocarbamol Formulations in Healthy Subjects Under Fasting Conditions: A Randomized, Open-Label, Crossover Clinical Trial. Pharmaceuticals, 18(3), 354.
https://doi.org/10.3390/ph18030354
